As of Oct 05
| +0.14 / +2.66%|
The 1 analysts offering 12-month price forecasts for ARCA Biopharma Inc have a median target of 26.25, with a high estimate of 26.25 and a low estimate of 26.25. The median estimate represents a +385.21% increase from the last price of 5.41.
The current consensus among 1 polled investment analysts is to Buy stock in ARCA Biopharma Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.